Did you mean: diagnose
Diagenode is an international life sciences company which mainly focus on innovative instruments and reagents systems for life science research.
The DIAGNODE-3 study will investigate whether an investigational drug called Diamyd® (rhGAD65) is able to preserve the body's own insulin-producing capacity ...
The aim of the current precision medicine phase 3 study is to determine whether intralymphatic administration of rhGAD65 preserves insulin ...
People also ask
Where is Diagenode headquarters?
The platform streamlines availability management for healthcare providers, enabling them to effortlessly establish and manage appointment time slots. They have ...
People also search for
DIAGNODE-3 is a phase III randomised, double-blind, placebo-controlled, international, multicentre, parallel-arm, 24-month trial in adolescents and adults with ...
Diagenode
Company
Diagenode is an international life sciences company which mainly focus on innovative instruments and reagents systems for life science research.
Parent organization: Hologic
Founded: 2003
Source: S&P Global Market Intelligence
No information is available for this page. · Learn why
The Phase III clinical trial DIAGNODE-3 is open for recently diagnosed type 1 diabetes patients at selected clinics.
Apr 4, 2023 · Diamyd Medical's precision medicine Phase 3 trial for Type 1 Diabetes, DIAGNODE-3, has enrolled 100 patients. To date, no serious adverse events ...
Sep 5, 2023 · DIAGNODE-3 is designed to confirm the efficacy and safety of the antigen-specific immunotherapy Diamyd® in patients aged 12 to 29 years recently ...
Sep 5, 2023 · DIAGNODE-3 is designed to confirm the efficacy and safety of the antigen-specific immunotherapy Diamyd® in patients aged 12 to 29 years recently ...